Last reviewed · How we verify
NCT04375982: NOVEL-3
Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests
NA trial testing Venepuncture in Embolism and Thrombosis in 200 participants. Status unknown.
5 April 2022
Quick facts
| Lead sponsor | LumiraDx UK Limited |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 200 |
| Start date | 20 April 2020 |
| Primary completion | 5 April 2022 |
| Estimated completion | 31 March 2024 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Venepuncture
- Fingerstick
Conditions studied
- Embolism and Thrombosis — all drugs for Embolism and Thrombosis →
- Infection — all drugs for Infection →
- Inflammation — all drugs for Inflammation →
Sponsor
LumiraDx UK Limited — full company profile →
Who can join
18 and older, any sex, with Embolism and Thrombosis or Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A Multicenter Study Conducted to Evaluate the Agreement between Fingerstick Whole Blood, Venous Whole Blood and Plasma Determined on the LumiraDx Point of Care D-Dimer and Point of Care CRP Tests to Results on the Reference Analyzer
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Performance Evaluation of the Quantitative Point-of-Care LumiraDx D-Dimer Test.
Ellis JE, Johnston TW, Craig D, Scribner A, et al · · 2021 · cited 5× · PMID 34618321 · DOI 10.1007/s40119-021-00241-7
Verify or expand the search:
- PubMed search for NCT04375982
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Venepuncture
Trials testing the same drug.
- NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
- NCT06876506 — Identification of B Regulatory Cells by Flow Cytometry · not yet recruiting
- NCT06648837 — Microvisk Continuous Blood Donation Study · NA · not yet recruiting
- NCT06444607 — Hereditary Pheochromocytoma Assessment of Tumour Immunologies · recruiting
- NCT05403853 — A Performance Evaluation of the Lumiradx Point of Care HbA1c Device · NA · completed
Other recruiting trials for Embolism and Thrombosis
Currently open trials in the same condition.
- NCT05853796 — Observational Dutch Young Symptomatic StrokE studY - nEXT · recruiting
- NCT05568966 — Collection of Blood Samples for New Diagnostic Devices 2 · NA · recruiting
- NCT04304651 — Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism · NA · recruiting
Other LumiraDx UK Limited trials
Trials by the same sponsor.
- NCT05787444 — Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory · unknown
- NCT05728970 — Performance Evaluation of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care (POC · completed
- NCT05568966 — Collection of Blood Samples for New Diagnostic Devices 2 · NA · recruiting
- NCT05506618 — Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2) · NA · unknown
- NCT05403853 — A Performance Evaluation of the Lumiradx Point of Care HbA1c Device · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04375982 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by LumiraDx UK Limited
- Last refreshed: 26 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04375982.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing